ANN LENTZ: Open Payments
NPI 1053757336 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 95 payments from 21 companies in 2025. Trend: 2023 $1,206 · 2024 $1,577 · 2025 $1,886
Food & beverage: $1,886
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $361 |
| Amgen Inc. | 11 | $353 |
| UCB, Inc. | 6 | $168 |
| PFIZER INC. | 13 | $161 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| Mallinckrodt Hospital Products Inc. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| ANI Pharmaceuticals, Inc. | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Fresenius Kabi USA, LLC | 3 | $62 |
Products named: RINVOQ, EVENITY, Bimzelx, SKYRIZI, OTEZLA, XELJANZ, ACTHAR, SAPHNELO.
Industry payments across VA — which companies pay providers there.
